BRIEF published on 06/16/2026 at 10:10, 1 month 9 days ago Giorgio Bargiani Wins Prestigious Bartending Award Mixology Europe's 50 Best Bars Giorgio Bargiani Connaught Bar Altos Bartenders' Bartender Award
BRIEF published on 06/16/2026 at 10:10, 1 month 9 days ago Giorgio Bargiani remporte un prestigieux prix de barman Mixologie Les 50 Meilleurs Bars D'Europe Giorgio Bargiani Connaught Bar Prix Altos Des Barmans
BRIEF published on 06/16/2026 at 10:05, 1 month 9 days ago Shell Recharge and SINEXCEL Open Joint Innovation Lab for EV Charging Sustainable Energy EV Charging Innovation Lab Shell Recharge SINEXCEL Partnership
BRIEF published on 06/16/2026 at 10:05, 1 month 9 days ago Shell Recharge et SINEXCEL ouvrent un laboratoire d'innovation commun pour la recharge des véhicules électriques Énergie Durable Laboratoire D'innovation Recharge Des Véhicules Électriques Recharge Shell Partenariat SINEXCEL
BRIEF published on 06/16/2026 at 10:05, 1 month 9 days ago S&P Upgrades BarmeniaGothaer Ratings to “A+”, Outlook Stable S&P Global Ratings Rating Upgrade Financial Stability BarmeniaGothaer Insurance Merger
BRIEF published on 06/16/2026 at 10:05, 1 month 9 days ago S&P relève la notation de BarmeniaGothaer à « A+ », perspective stable S&P Global Ratings Stabilité Financière BarmeniaGothaer Amélioration De La Notation Fusion D'assurances
BRIEF published on 06/16/2026 at 10:05, 1 month 9 days ago PL BioScience Welcomes Maik W. Jornitz to Board of Directors Board Of Directors Biopharmaceutical Growth Human Platelet Lysate PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:05, 1 month 9 days ago PL BioScience accueille Maik W. Jornitz au sein de son conseil d'administration. Conseil D'administration Croissance Biopharmaceutique Lysat Plaquettaire Humain PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:00, 1 month 9 days ago Innovative Molecules Advances with New EBV Antiviral Program Clinical-stage Innovative Molecules EBV Virology Pipeline Antiviral Program
BRIEF published on 06/16/2026 at 10:00, 1 month 9 days ago Des molécules innovantes progressent grâce à un nouveau programme antiviral contre le virus d'Epstein-Barr Stade Clinique Molécules Innovantes EBV Pipeline De Virologie Programme Antiviral
Published on 07/25/2026 at 00:35, 12 hours 57 minutes ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 14 hours 32 minutes ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 15 hours 17 minutes ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 15 hours 27 minutes ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 17 hours 32 minutes ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/24/2026 at 18:44, 18 hours 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:15, 19 hours 17 minutes ago EUROPLASMA: Tirage des deux premières tranches du financement obligataire en vue de l’émission de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2 M€
Published on 07/24/2026 at 17:50, 19 hours 41 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 18:50, 18 hours 41 minutes ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 18 hours 41 minutes ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 19 hours 8 minutes ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group
Published on 07/24/2026 at 18:11, 19 hours 20 minutes ago H1 2026 liquidity contract statement for TF1
